Most colorectal patients report financial burden due to treatment
the ONA take:
The burden of cancer and its treatment goes beyond the obvious medical and physical challenges. Many patients experience significant financial hardship as well. Researchers at the University of Michigan Comprehensive Cancer Center conducted a study on the financial burden of colorectal cancer.
They surveyed 956 patients identified through the Surveillance, Epidemiology and End Results cancer registries for the Metro Detroit area and the stage of Georgia. The patients were asked to complete a seven-question survey that asked whether they employed such financial strategies as using savings, borrowing money, skipping bill payments, or cutting back on expenses (eg, food, clothing, or recreational activities).
Overall, 62% of respondents indicated areas of burdens, based on the seven questions. More specifically, the study demonstrated that younger patients who worked in low-paying jobs and those who received chemotherapy were most likely to endure financial burdens.
Based on their findings, the researchers advocate changes to job-related policies that would allow patients to focus on adhering to their treatments, and provide support for both copays and nonmedical expenses related to getting to treatment appointments. Most importantly, however, the researchers encourage clinicians to openly discuss financial situations and support options with patients.
Researchers conducted a study on the financial burden of colorectal cancer.
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy and among younger patients who worked in low-paying jobs.
The study surveyed 956 patients who had been treated for stage 3 colorectal cancer. Among this group, chemotherapy is known to increase survival by up to 20 percent and is routinely recommended following surgery.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|